Gestational Trophoblastic Disease: A Study of Mode of Evacuation and Subsequent Need for Treatment with Chemotherapy

By Tidy J.A.   Gillespie A.M.   Bright N.   Radstone C.R.   Coleman R.E.   Hancock B.W.  

Gynecologic Oncology, Vol. 78, Iss. 3, 2000-09 ,pp. : 309-312

Elsevier

Access to resources Recommend Favorite

Is Lack of Response to Single-Agent Chemotherapy in Gestational Trophoblastic Disease Associated with Dose Scheduling or Chemotherapy Resistance?

By Kohorn E.I.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 36-39

Elsevier

Access to resources Recommend Favorite

Combination Chemotherapy with Methotrexate, Etoposide, and Actinomycin D for High-Risk Gestational Trophoblastic Tumors

By Matsui H.   Suzuka K.   Iitsuka Y.   Seki K.   Sekiya S.  

Gynecologic Oncology, Vol. 78, Iss. 1, 2000-07 ,pp. : 28-31

Elsevier

Access to resources Recommend Favorite

Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy*

By Escobar P.F.   Lurain J.R.   Singh D.K.   Bozorgi K.   Fishman D.A.  

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 552-557

Elsevier

Access to resources Recommend Favorite

Experience with platinum-based and high-dose chemotherapy in patients with gestational trophoblastic disease: possible implications for future management

By Markman Maurie  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 7, 2004-07 ,pp. : 383-387

Springer Publishing Company

Access to resources Recommend Favorite